Orchestra BioMed Holdings, Inc. (OBIO)
$5.18+$0.07 (+1.47%) Today
David P. Hochman - Officer
Jason Aryeh - DirectorJason Aryeh - DirectorDavid P. Hochman - OfficerOrchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
https://www.orchestrabiomed.comSEC filings for OBIO on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 7,000 | $30K |
| Open-market sale | 3 | 45,000 | $183K |
| Grant or award | 9 | 235,571 | |
| Tax withholding / forfeiture | 14 | 84,216 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
70 Form 4 filings on record, the earliest from Dec 6, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joshua Aiello - Officer | Grant or award | Stock Option (Right to Buy) | 70,000 | $0.00 | - | |
| Darren Sherman - Officer | Grant or award | Common Stock, par value $0.0001 per share | 397,000 | $0.00 | - | |
| Andrew Lawrence Taylor - Officer | Grant or award | Common Stock, par value $0.0001 per share | 181,000 | $0.00 | - | |
| David P. Hochman - Officer | Grant or award | Common Stock, par value $0.0001 per share ("Common Stock") | 504,000 | $0.00 | - | |
| Chris Cleary - Director | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share ("Common Stock") | 676 | $3.71 | $3K | |
| Darren Sherman - Officer | Grant or award | Stock Option | 34,974 | $0.00 | - | |
| Darren Sherman - Officer | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share | 40,340 | $5.35 | $216K | |
| Andrew Lawrence Taylor - Officer | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share | 3,071 | $5.35 | $16K | |
| David P. Hochman - Officer | Open-market purchase | Common Stock, par value $0.0001 per share ("Common Stock") | 5,000 | $4.07 | $20K | |
| David P. Hochman - Officer | Tax withholding / forfeiture | Common Stock | 3,283 | $4.18 | $14K | |
| David P. Hochman - Officer | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share ("Common Stock") | 3,283 | $4.18 | $14K | |
| Jason Aryeh - Director | Open-market purchase | Common Stock, par value $0.0001 per share | 1,000 | $2.45 | $2K | |
| Andrew Lawrence Taylor - Officer | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share | 16,102 | $2.46 | $40K | |
| David P. Hochman - Officer | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share (Common Stock) | 40,355 | $2.46 | $99K | |
| David P. Hochman - Officer | Tax withholding / forfeiture | Common Stock | 3,283 | $2.46 | $8K | |
| Joshua Aiello - Officer | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share (Common Stock) | 203 | $2.46 | $499 | |
| Darren Sherman - Officer | Tax withholding / forfeiture | Common Stock, par value $0.0001 per share | 40,340 | $2.72 | $110K | |
| Eric S. Fain - Director | Open-market purchase | Common Stock, par value $0.0001 per share | 5,760 | $2.61 | $15K | |
| David P. Hochman - Officer | Open-market purchase | Common Stock, par value $0.0001 per share (Common Stock) | 6,000 | $2.49 | $15K | |
| Darren Sherman - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 3,000 | $2.62 | $8K | |
| Andrew Lawrence Taylor - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 2,000 | $2.55 | $5K | |
| Eric S. Fain - Director | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 7,500 | $0.00 | - | |
| Eric S. Fain - Director | Grant or award | Common Stock | 7,500 | $0.00 | - | |
| Pamela Ann Connealy - Director | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 15,000 | $0.00 | - | |
| Darren Sherman - Officer | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 120,000 | $0.00 | - | |
| Joshua Aiello - Officer | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 15,000 | $0.00 | - | |
| Chris Cleary - Director | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 15,000 | $0.00 | - | |
| John Prosper Mack - Director | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 15,000 | $0.00 | - | |
| Jason Aryeh - Director | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 15,000 | $0.00 | - | |
| David P. Hochman - Officer | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 100,000 | $0.00 | - | |
| David P. Hochman - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| Andrew Lawrence Taylor - Officer | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 80,000 | $0.00 | - | |
| David Pacitti - Director | Grant or award | Common Stock, par value $0.0001 per share (Common Stock) | 15,000 | $0.00 | - | |
| PERCEPTIVE ADVISORS LLC | Open-market purchase | Common Stock | 700,000 | $2.75 | $1.93M | |
| PERCEPTIVE ADVISORS LLC | Open-market purchase | Pre-funded Warrants (right to buy) | 1,500,000 | $2.75 | $4.12M |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Orchestra BioMed Holdings, Inc. (OBIO) had 19 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for OBIO runs to 70 Form 4 filings, the earliest from 2024-12-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of OBIO were filed in the last 90 days, totaling $30K.
3 insider sales of OBIO were filed in the last 90 days, totaling $183K.
This page tracks OBIO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add OBIO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
